Ferrlecit (iron) 62.5 mg in 5 mL Injection
RxNorm 261123
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 261123 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Ferrlecit (iron) 62.5 mg in 5 mL Injection.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SYPrescribable
Synonym (SY):
5 mL Ferrlecit 12.5 mg/ML Injection
(Atom ID: 8690673)
SBDPrescribable
Semantic Branded Drug (SBD):
5 mL sodium ferric gluconate complex 12.5 mg/ML Injection [Ferrlecit]
(Atom ID: 12371805)
SYPrescribable
Synonym (SY):
Ferrlecit (as elemental iron) 62.5 mg per 5 mL Injection
(Atom ID: 8698752)
PSNPrescribable
Prescribable Name (PSN):
Ferrlecit (iron) 62.5 mg in 5 mL Injection
(Atom ID: 10272051)
Patient Education
Sodium Ferric Gluconate Injection
Sodium ferric gluconate injection is used to treat iron-deficiency anemia (a lower than normal number of red blood cells due to too little iron) in adults and children 6 years of age and older with chronic kidney disease (damage to the kidneys which may worsen over time and may cause the kidneys to stop working) who are on dialysis and are also receiving the medication epoetin (Epogen, Procrit). Sodium ferric gluconate injection is in a class of medications called iron replacement products. It works by replenishing iron stores so that the body can make more red blood cells.
[Learn More]
* Please review the disclaimer below.